E&Investment Inc. 13D/13G Filings for NeuroBo Pharmaceuticals, Inc. (NRBO)

E&Investment Inc. 13D and 13G filings for NeuroBo Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-08-05
4:25 pm
Sale		 2022-07-26 13D NeuroBo Pharmaceuticals, Inc.
NRBO		 E&Investment Inc. 25,474
22.900%		 -5,033decrease
(-16.50%)		 Filing
2021-08-30
10:27 am
Unchanged		 2021-08-27 13D NeuroBo Pharmaceuticals, Inc.
NRBO		 E&Investment Inc. 30,507
32.900%		 0
(Unchanged)		 Filing
2021-03-15
06:05 am
Unchanged		 2021-03-09 13D NeuroBo Pharmaceuticals, Inc.
NRBO		 E&Investment Inc. 30,507
33.000%		 0
(Unchanged)		 Filing